VP of M&A and Corporate Development at a publicly traded post-acute healthcare services organization with over $6B in annual revenue spanning four distinct service lines.
Managed M&A for a primary outpatient service line/division while also supporting other service lines as needed.
Completed 20 multi-location deals in 2024, with an average transaction value of $20M.
Directed a team of two, having established the M&A function to support the outpatient division with joint ventures, partnerships, and acquisitions.
Led outpatient M&A initiatives and projects ranging from small to large-scale transactions, including collaborations with orthopedic surgeons.
Employs four sourcing strategies—brokers, investment banks, grassroots referrals, and cold outreach—utilizing analytics to identify opportunities.
Developed and prioritized the pipeline by targeting deals that achieve post-close synergized EBITDA and meet thresholds.